Research Center for Drug Discovery and Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo 105-8512, Japan; Division of Biochemistry, Faculty of Pharmacy and Graduate School of Pharmaceutical Sciences, Keio University, Tokyo 105-8512, Japan.
Department of Biochemistry, Keio University School of Medicine, Tokyo 160-8582, Japan.
Cell Rep. 2022 Jul 19;40(3):111087. doi: 10.1016/j.celrep.2022.111087.
Microbiota-accessible carbohydrates (MACs) exert health-promoting effects, but how each MAC impacts gut microbiota and regulates host physiology remains unclear. Here, we show that l-arabinose and sucrose cooperatively act on gut microbiota and exert anti-obesogenic effects. Specifically, l-arabinose, a monosaccharide that is poorly absorbed in the gut and inhibits intestinal sucrase, suppresses diet-induced obesity in mice in the presence of sucrose. Additionally, the suppressive effect of l-arabinose on adiposity is abrogated in mice lacking the short-chain fatty acid (SCFA) receptors GPR43 and GPR41. Mechanistically, l-arabinose increases the relative abundance of acetate and propionate producers (e.g., Bacteroides), while sucrose enhances SCFA production. Furthermore, l-arabinose and sucrose activate the glycolytic and pentose phosphate pathways of Bacteroides, respectively, indicating that they synergistically promote acetate production through distinct pathways. These findings suggest that each MAC has a unique property and thus may serve as a precision gut-microbiota modulator to promote host homeostasis.
微生物可利用碳水化合物(MACs)具有促进健康的作用,但每种 MAC 如何影响肠道微生物群并调节宿主生理机能仍不清楚。在这里,我们表明,阿拉伯糖和蔗糖协同作用于肠道微生物群并发挥抗肥胖作用。具体来说,阿拉伯糖是一种在肠道中吸收不良并抑制肠蔗糖酶的单糖,在蔗糖存在的情况下可抑制小鼠的饮食诱导肥胖。此外,在缺乏短链脂肪酸(SCFA)受体 GPR43 和 GPR41 的小鼠中,阿拉伯糖对肥胖的抑制作用被消除。从机制上讲,阿拉伯糖增加了乙酸盐和丙酸盐产生菌(例如拟杆菌)的相对丰度,而蔗糖则增强了 SCFA 的产生。此外,阿拉伯糖和蔗糖分别激活了拟杆菌的糖酵解和磷酸戊糖途径,表明它们通过不同的途径协同促进乙酸盐的产生。这些发现表明,每种 MAC 都具有独特的特性,因此可以作为一种精准的肠道微生物调节剂来促进宿主内稳态。